Combined analysis of chromosomal instabilities and gene expression for colon cancer progression inference

Journal of Clinical Bioinformatics

Volumn 4, Issue 1, 2014, Pages

  Cava, Claudia ^a   Zoppis, Italo ^b   Gariboldi, Manuela ^c,d   Castiglioni, Isabella ^a   Mauri, Giancarlo ^b   Antoniotti, Marco ^b  

^a CNR   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

Colorectal cancer; Copy number alteration; Dissimilarity representation; Support vector machine

Indexed keywords

EID: 84896375557     PISSN: None     EISSN: 20439113     Source Type: Journal    
DOI: 10.1186/2043-9113-4-2     Document Type: Article

References (46)

1. Haq AI, Schneeweiss J, Kalsi V, Arya M. The dukes staging system: a cornerstone in the clinical management of colorectal cancer. Lancet Oncol 2009, 10(11):1128. 10.1016/S1470-2045(09)70157-3, 19880067.
2. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new american joint committee on cancer sixth edition staging. J Nat Cancer Inst 2004, 96(19):1420-1425. 10.1093/jnci/djh275, 15467030.
3. Shen L, Toyota M, Kondo Y, Lin E, Zhang L, Guo Y, Hernandez NS, Chen X, Ahmed S, Konishi K, Hamilton SR, Issa J-PJ. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Nat Acad Sci 2007, 104(47):18654-18659. 10.1073/pnas.0704652104, 2141832, 18003927.
4. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. Genetic alterations during colorectal-tumor development. N Engl J Med 1988, 319:3526-3535.
5. Fearon ER, Vogelstein B. Genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767. 10.1016/0092-8674(90)90186-I, 2188735.
6. Reid JF, Gariboldi M, Sokolova V, Capobianco P, Lampis A, Perrone F, Signoroni S, Costa A, Leo E, Pilotti S, Pierotti MA. Integrative approach for prioritizing cancer genes in sporadic colon cancer. Genes Chromosom Cancer 2009, 48(11):953-962. 10.1002/gcc.20697, 19672874.
7. Mathew JP, Taylor BS, Bader GD, Pyarajan S, Antoniotti M, Chinnaiyan AM, Sander C, Burakoff SJ, Mishra B. From bytes to bedside: Data integration and computational biology for translational cancer research. PLoS Comutational Biol 2007, 3(2):e12.
8. Leslie A, Pratt NR, Gillespie K, Sales M, Kernohan NM, Smith G, Wolf CR, Carey FA, Steele RJC. Mutations of apc, k-ras, and p53 are associated with specific chromosomal aberrations in colorectal adenocarcinomas. Cancer Res 2003, 63(15):4656-4661.
9. Bomme L, Bardi G, Pandis N, Fenger C, Kronborg O, Heim S. Clonal karyotypic abnormalities in colorectal adenomas: clues to the early genetic events in the adenoma-carcinoma sequence. Genes Chromosomes Cancer 1994, 10(3):190-196. 10.1002/gcc.2870100307, 7522042.
10. Ghadimi BM, Grade M, Liersch T, Langer C, Siemer A, Fuzesi L, Becker H. Gain of chromosome 8q23-24 is a predictive marker for lymph node positivity in colorectal cancer. Clin Cancer Res 2003, 9(5):1808-1814.
11. Balsara BR, Testa JR. Chromosomal imbalances in human lung cancer. Oncogene 2002, 21(45):6877-6883. 10.1038/sj.onc.1205836, 12362270.
12. Schlomm T, Kirstein P, Iwers L, Daniel B, Steuber T, Walz J, Chun FHK, Haese A, Kollermann J, Graefen M, et al. Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer. Clin Cancer Res 2007, 13(22 Pt 1):6579-6584.
13. Chin K, Devries S, Fridlyand J, Spellman P, Roydasgupta R, Kuo WL, Lapuk A, Neve R, Qian Z, Ryder T, Chen F, Feiler H, Tokuyasu T, Kingsley C, Dairkee S, Meng Z, Chew K, Pinkel D, Jain A, Ljung B, Esserman L, Albertson D, Waldman F, Gray J. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 2006, 10:529-541. 10.1016/j.ccr.2006.10.009, 17157792.
14. Chin SF, Teschendorff AE, Marioni JC, Wang Y, Barbosa-Morais NL, Thorne NP, Costa JL, Pinder SE, van de Wiel MA, Green AR, Ellis IO, Porter PL, Tavare S, Brenton JD, Ylstra B, Caldas C. High-resolution array-cgh and expression profiling identifies a novel genomic subtype of er negative breast cancer. Genome Biol 2007, 8:215. 10.1186/gb-2007-8-5-215, 1929136, 17543136.
15. Rennstam K, Ahlstedt-Soini M, Baldetorp B, Bendahl P, Borg A, Karhu R, Tanner M, Tirkkonen M, Isola J. Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization. Cancer Res 2003, 63(24):8861-8868.
16. Cava C, Zoppis I, Gariboldi M, Castiglioni I, Mauri G, Antoniotti M. Copy number alterations for tumor progression inference. Artificial Intelligence in Medicine. Lecture Notes in Computer Science 2013, 104-109. Berlin Heidelberg: Springer, Peek N, Marín Morales R, Peleg M.
17. Cava C, Zoppis I, Mauri G, Ripamonti M, Gallivanone F, Salvatore C, Gilardi M, Castiglioni I. Combination of gene expression and genome copy number alteration has a prognostic value for breast cancer. Engineering in Medicine and Biology Society (EMBC), Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society EMBS 2013, 608-611. Osaka: IEEE.
18. Chin S, Teschendorff A, Marioni J, Wang Y, Morais NB, Thorne N, Costa J, Pinder S, van de Wiel M, Green A, Ellis I, Porter P, Tavare S, Brenton J, Ylstra B, Caldas C. High-resolution array-CGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Genome Biol 2007, 8(10):R215. 10.1186/gb-2007-8-10-r215, 2246289, 17925008.
19. Callagy G, Pharoah P, Chin S-F, Sangan T, Daigo Y, Jackson L, Caldas C. Identification and validation of prognostic markers in breast cancer with the complementary use of array-cgh and tissue microarrays. J Pathol 2005, 205(3):388-396. 10.1002/path.1694, 15682439.
20. Andre F, Job B, Dessen P, Tordai A, Michiels S, Liedtke C, Richon C, Yan K, Wang B, Vassal G, Delaloge S, Hortobagyi GN, Symmans WF, Lazar V, Pusztai L. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Clin Cancer Research : Official J Am Assoc Cancer Res 2009, 15(2):441-451.
21. Duda RO, Hart PE, Stork DG. Pattern Classification 2001, New York: A Wiley-Interscience Publication Wiley.
22. Pekalska E, Duin RPW. The Dissimilarity Representation for Pattern Recognition: Foundations And Applications (Machine Perception) 2005, River Edge, USA: World Scientific Publishing Company.
23. Duda RO, Hart PE, Stork DG. Pattern Classification and Scene Analysis 1973, New York: Wiley.
24. Theodoridis S, Koutroumbas K. Pattern Recognition 2006, Orlando, FL, USA: Academic Press, Inc.
25. Ramakrishnan N, Tadepalli S, Watson LT, Helm RF, Antoniotti M, Mishra B. Reverse engineering dynamic temporal models of biological processes and their relationships. PNAS 2010, 107(28):12511-12516. 10.1073/pnas.1006283107, 2906599, 20571120.
26. Thomassen M, Tan Q, Kruse TA. Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancer. BMC Cancer 2008, 8:1394.
27. Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, Desmedt C, Ignatiadis M, Sengstag T, Schütz F, Goldstein DR, Piccart M, Delorenzi M. Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res 2008, 10(4):R65. 10.1186/bcr2124, 2575538, 18662380.
28. Gene Expression Omnibus (GEO). http://www.ncbi.nlm.nih.gov/geo/.
29. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4(2):249-264.
30. Breitling R, Armengaud P, Amtmann A, Herzyk P. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 2004, 573(5):83-92.
31. MeV: MultiExperiment Viewer. http://www.tm4.org/mev_manual/rp.html.
32. Netaffx Tool. http://www.affymetrix.com/analysis/index.affx.
33. Kurashina K, Yamashita Y, Ueno T, Koinuma K, Ohashi J, Horie H, Miyakura Y, Hamada T, Haruta H, Hatanaka H, Soda M, Choi YL, Takada S, Yasuda Y, Nagai H, Mano H. Chromosome copy number analysis in screening for prognosis-related genomic regions in colorectal carcinoma. Cancer Sci 2008, 99(9):1835-1840. 10.1111/j.1349-7006.2008.00881.x, 18564138.
34. Kikuchi A, Ishikawa T, Mogushi K, Ishiguro M, Iida S, Mizushima H, Uetake H, Tanaka H, Sugihara K. Identification of nucks1 as a colorectal cancer prognostic marker through integrated expression and copy number analysis. Int J Cancer 2012, 132(10):2295-2302.
35. Nannya Y, Sanada M, Nakazaki K, Hosoya N, Wang L, Hangaishi A, Kurokawa M, Chiba S, Bailey D, Kennedy G. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res 2005, 65(14):6071-6079. 10.1158/0008-5472.CAN-05-0465, 16024607.
36. Bioconductor Software. http://bioconductor.wustl.edu/bioc.
37. Mierswa I, Wurst M, Klinkenberg R, Scholz M, Euler T. YALE: rapid prototyping for complex data mining tasks. KDD '06: Proceedings of the 12th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining 2006, 935-940. Philadelphia, USA: ACM, Ungar L, Craven M, Gunopulos D, Eliassi-Rad T.
38. Zoppis I, Gianazza E, Borsani M, Chinello C, Mainini V, Galbusera C, Ferrarese C, Galimberti G, Sorbi S, Borroni B, Magni F, Antoniotti M, Mauri G. Mutual information optimization for mass spectra data alignment. IEEE/ACM Trans Comput Biol Bioinform 2012, 9(3):934-939.
39. Guyon I, Gunn S, Nikravesh M, Zadeh LA. Feature Extraction: Foundations and Applications 2006, New York: Springer.
40. Rapid Miner Documentation. http://rapid-i.com.
41. Japkowicz N, Shah M. Evaluating Learning Algorithms: A Classification Perspective 2011, New York, NY, USA.
42. Cancer Genes. http://cbio.mskcc.org/tools/cancer-genomics/index.html.
43. Cancer Genome Anathomy Project. http://cgap.nci.nih.gov/Genes.
44. Li A, Lu D, Zhang Y, Li J, Fang Y, Li F, Sun J. Critical role of aquaporin-3 in epidermal growth factor-induced migration of colorectal carcinoma cells and its clinical significance. Oncol Rep 2012, 29(2):535-540.
45. Wu X-S, Xi H-Q, Chen L. Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival. World J Surg Oncol 2012, 10(1):244. 10.1186/1477-7819-10-244, 3506563, 23153436.
46. Miyoshi N, Ishii H, Mimori K, Sekimoto M, Doki Y, Mori M. Scrn1 is a novel marker for prognosis in colorectal cancer. J Surg Oncol 2010, 101(2):156-159.